2Martin AR, Moyes CD, Lucas CR, et al. Hepatitis B infection in households of HBsAg positive New Zealand children. N Z Med J, 1996,109:463-465.
3Noppompanth S, Sathirapongsasuti N, Chongsrisawat V, et al. Detection of HBsAg and HBV DNA in serum and saliva of HBV carriers. Southeast Asian .J Trop Med Public Health,2000,31:419-421.
4Luksami P, Maneesri P, Kittigul L. Hepatitis B seroprevalence and risk factors among school - age children in a low socioeconomic community,Bangkok. Asia Pac J Public Heaflh, 1995,8:158-161.
5Williams CA,Weber FT, McKim M,et al.Hepatitis B virus transmission in a public school: effects of mentally retarded HBsAg carrier students. Am J Public Health, 1987,77: 476-478.
6Schastnyi EI, Muliar IS, Kuzin SN, et al. The risk of becoming infected with hepatitis B and C virus in the pupils of children' s boarding schools. ZhMikrobiol Epidemiol Immunobiol, 1996, (2) :29-32.
7Zhang LX,Tu DH,He GX, et al. Risk of tuberculosis infection and tuberculosis meningitis after discontinuation of BCG in Beijing[J]. Am J Respir Crit Care Med, 2000,162:1314～1317
8IUAT Commitee on Prophlaxis. Efficacy of various duration of isoniazid prevetive therapy to tuberculosis:five years of follow up in the IUAT trial[M]. Bull WHO, 1982,60:555～64
9Hong Kong Chest Service/Tuberculosis Research Centre, British Medical Research Council. A double-blind placebo-controlled Clinical of three anti tuberculosis chemoprophylaxia regimens in patients with silicosis in Hong Kong[J]. Am Respir Dis, 1992,145:36～41
10Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommen dations Against the Use of Rifampin and Pyrazinamide for Treatment of Letent Tuberculosis Infection-United States 2003[J]. MMWR 2003,52:735～739
